Yale University

ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study (2026) Kuemmel S, Fasching P, Schmid P, Harbeck N, Takahashi M, Untch M, Boileau JF, et al. Journal article An introduction to BASIC Guide: human biomonitoring and surveillance of chemical exposure in occupational settings. (2026) Zare Jeddi M, Jones K, Leese E, Fustinoni S, Galea KS, Santonen T, Porras SP, et al. Journal article, Editorial Perihematomal Edema and Functional Outcome After Intracerebral Hemorrhage: A Meta-Analysis of Individual Participant Data (2026) Samarasekera N, Tuck S, Wang X, Anderson CS, Shirazian A, Volbers B, Huttner H, et al. Journal article Immune checkpoint inhibitor-associated myocarditis: A novel risk score (2026) Power JR, Dolladille C, Ozbay B, Procureur A, Ederhy S, Palaskas NL, Lehmann LH, et al. Journal article Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial (2026) Mann JF, Marx N, Deanfield JE, Emerson SS, Inzucchi SE, McGuire DK, Mulvagh SL, et al. Journal article Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study (2026) Kaulen LD, Nayak L, Karschnia P, Kraai I, Galluzzo D, de Groot FA, Witterholt M, et al. Journal article Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials (2026) Müller-Wieland D, McGuire DK, Lincoff AM, Buse JB, Mann JF, Inzucchi SE, Pop-Busui R, et al. Journal article Apremilast improves skin outcomes in pediatric plaque psoriasis of shorter disease duration: 52-week results from the SPROUT phase 3 trial (2026) Langley RG, Arkin L, Fiorillo L, Eichenfield LF, Lebwohl M, Strober B, Sticherling M, et al. Journal article Adipose-mimetic granular hydrogels uncover biophysical cues driving breast cancer invasion (2026) Knode BK, Beeghly GF, Schutrum BE, Wang D, Zheng Y, Battistella A, Goswami R, et al. Journal article Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study (2026) Kuemmel S, Fasching P, Schmid P, Harbeck N, Takahashi M, Untch M, Boileau JF, et al. Journal article